Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
3.025
+0.035 (1.17%)
Nov 5, 2024, 11:12 AM EST - Market open
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $401.04 million as of November 5, 2024. Its market cap has increased by 32.79% in one year.
Market Cap
401.04M
Enterprise Value
419.37M
1-Year Change
32.79%
Ranking
Category
Stock Price
$3.03
Market Cap Chart
Since January 5, 2017, Organogenesis Holdings's market cap has increased from $376.60M to $401.04M, an increase of 6.49%. That is a compound annual growth rate of 0.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2024 | 396.40M | -26.59% |
| Dec 29, 2023 | 540.00M | 53.32% |
| Dec 30, 2022 | 352.20M | -70.37% |
| Dec 31, 2021 | 1.19B | 46.45% |
| Dec 31, 2020 | 811.60M | 78.10% |
| Dec 31, 2019 | 455.70M | 30.13% |
| Dec 31, 2018 | 350.20M | -8.90% |
| Dec 29, 2017 | 384.40M | 2.07% |
| Jan 5, 2017 | 376.60M | - |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 425.07M |
| 4D Molecular Therapeutics | 424.85M |
| GH Research | 416.23M |
| Theravance Biopharma | 401.65M |
| ZimVie | 398.25M |
| MaxCyte | 393.04M |
| Esperion Therapeutics | 392.45M |
| Akebia Therapeutics | 389.03M |